Contact Us
Drug Search Results
More Filters [+]

ML-004

Alternative Names: ml-004, ml 004, ml004
Latest Update: 2024-09-03
Latest Update Note: Clinical Trial Update

Product Description

ML-004 is being developed by MapLight Therapeutics for the treatment of autism spectrum disorder. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT05081245?term=ML-004&draw=2&rank=1)

Mechanisms of Action: 5-HT Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: MapLight Therapeutics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ML-004

Countries in Clinic: Australia, Canada, United States

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Autism Spectrum Disorder

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ML-004-003

P2

Enrolling by invitation

Autism Spectrum Disorder

2026-05-01

ML-004-002

P2

Recruiting

Autism Spectrum Disorder

2025-03-31

Recent News Events

Date

Type

Title

05/28/2024

News Article

 Sun Peak Metals Announces Encouraging Assay Results from 2020 Drill Program

11/23/2020

News Article

 MapLight Therapeutics Announces Completion of Dosing in Phase 1 Study of Therapy for Social Deficit in Autism Spectrum Disorder

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions